Veracyte, Inc.
METHODS FOR EVALUATING LUNG CANCER STATUS

Last updated:

Abstract:

The disclosure in some aspects provides methods of determining the likelihood that a subject has lung cancer based on the expression of informative-genes. In other aspects, the disclosure provides methods for determining an appropriate diagnostic intervention plan for a subject based on the expression of informative-genes. Related compositions and kits are provided in other aspects of the disclosure.

Status:
Application
Type:

Utility

Filling date:

15 May 2020

Issue date:

11 Feb 2021